UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

p53 Modulates Acquired Resistance to EGFR Inhibitors and Radiation

Cancer research (Chicago, Ill.), 2011-11, Vol.71 (22), p.7071-7079

2011

Volltextzugriff (PDF)

Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): Combining anti-EGFR antibody with tyrosine kinase inhibitor

Cancer research (Chicago, Ill.), 2004-08, Vol.64 (15), p.5355-5362

2004

Volltextzugriff (PDF)

Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (tarceva)

Cancer research (Chicago, Ill.), 2005-04, Vol.65 (8), p.3328-3335

2005

Volltextzugriff (PDF)

Insulin growth factor 1 like receptor (IGF-1R)

BMC cancer, 2016-10, Vol.16 (1), Article 773

2016

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab

Cancer biology & therapy, 2009-04, Vol.8 (8), p.696-703

2009

Volltextzugriff (PDF)

Enhancement of radiation response with bevacizumab

Journal of experimental & clinical cancer research, 2012-04, Vol.31 (1), p.37-37, Article 37

2012

Volltextzugriff (PDF)

Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer Cells

Clinical cancer research, 2009-03, Vol.15 (5), p.1585-1592

2009

Volltextzugriff (PDF)

Augmentation of Radiation Response by Panitumumab in Models of Upper Aerodigestive Tract Cancer

International journal of radiation oncology, biology, physics, 2008-10, Vol.72 (2), p.534-542

2008

Volltextzugriff (PDF)

Sym004, a novel anti-EGFR antibody mixture, augments radiation response in human lung and head and neck cancers

Molecular cancer therapeutics, 2013-12, Vol.12 (12), p.2772-2781

2013

Volltextzugriff (PDF)

Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation

Cancer research (Chicago, Ill.), 2013-01, Vol.73 (2), p.824-833

2013

Volltextzugriff (PDF)

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (13), p.3929-3941

2016

Volltextzugriff (PDF)

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

Oncogene, 2008-06, Vol.27 (28), p.3944-3956

2008

Volltextzugriff (PDF)

Small Molecule Inhibition of MDM2-p53 Interaction Augments Radiation Response in Human Tumors

Molecular cancer therapeutics, 2015-09, Vol.14 (9), p.1994-2003

2015

Volltextzugriff (PDF)

Abstract 2102A: Simultaneous targeting of EGFR and ALK in EML4-ALK positive lung cancer to inhibit tumor cell proliferation and migration

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2102-2102A

2016

Volltextzugriff (PDF)

Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers

Molecular cancer therapeutics, 2015-09, Vol.14 (9), p.2049-2059

2015

Volltextzugriff (PDF)

Erratum to: Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab

BMC cancer, 2016-12, Vol.16 (1), p.928-928, Article 928

2016

Volltextzugriff (PDF)

Abstract 2630: Inhibition of angiogenesis contributes to enhanced radiation response in tumors following MDM2 inhibition by AMG 232

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2630-2630

2015

Volltextzugriff (PDF)

Abstract 3309: Co-inhibition of ALK and EGFR and/or c-MET on cell growth and response to radiation in ALK-positive NSCLC cells

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3309-3309

2015

Volltextzugriff (PDF)

Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models

Clinical cancer research, 2016-02, Vol.22 (3), p.633-643

2016

Volltextzugriff (PDF)

Dual-Agent Molecular Targeting of the Epidermal Growth Factor Receptor (EGFR)

Cancer research (Chicago, Ill.), 2004-08, Vol.64 (15), p.5355-5362

2004

Volltextzugriff (PDF)

Abstract 856: Combination of crizotinib and radiation in the treatment of ALK-positive and cetuximab-resistant lung cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.856-856

2014

Volltextzugriff (PDF)

Abstract 4495: Sym013, novel pan-HER monoclonal antibody mixture, augments radiation response in human lung and head and neck tumors

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4495-4495

2014

Volltextzugriff (PDF)

Abstract 2610: AMG 232, a small molecular inhibitor of MDM2 augments radiation response in human tumors harboring wild-type p53

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2610-2610

2014

Volltextzugriff (PDF)

Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma

Discovery medicine, 2013-09, Vol.16 (87), p.79-92

2013

Volltextzugriff (PDF)

Abstract 4013: Transcriptionally mediated effects of radiation on the expression of immune susceptibility markers in murine and human melanoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4013-4013

2016

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(40)

Sprache

Englisch
(39)
Japanisch
(8)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

p53 Modulates Acquired Resistance to EGFR Inhibitors and Radiation

Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): Combining anti-EGFR antibody with tyrosine kinase inhibitor

Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (tarceva)

Insulin growth factor 1 like receptor (IGF-1R)

Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab

Enhancement of radiation response with bevacizumab

Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer Cells

Augmentation of Radiation Response by Panitumumab in Models of Upper Aerodigestive Tract Cancer

Sym004, a novel anti-EGFR antibody mixture, augments radiation response in human lung and head and neck cancers

Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

Small Molecule Inhibition of MDM2-p53 Interaction Augments Radiation Response in Human Tumors

Abstract 2102A: Simultaneous targeting of EGFR and ALK in EML4-ALK positive lung cancer to inhibit tumor cell proliferation and migration

Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers

Erratum to: Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab

Abstract 2630: Inhibition of angiogenesis contributes to enhanced radiation response in tumors following MDM2 inhibition by AMG 232

Abstract 3309: Co-inhibition of ALK and EGFR and/or c-MET on cell growth and response to radiation in ALK-positive NSCLC cells

Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models

Dual-Agent Molecular Targeting of the Epidermal Growth Factor Receptor (EGFR)

Abstract 856: Combination of crizotinib and radiation in the treatment of ALK-positive and cetuximab-resistant lung cancer

Abstract 4495: Sym013, novel pan-HER monoclonal antibody mixture, augments radiation response in human lung and head and neck tumors

Abstract 2610: AMG 232, a small molecular inhibitor of MDM2 augments radiation response in human tumors harboring wild-type p53

Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma

Abstract 4013: Transcriptionally mediated effects of radiation on the expression of immune susceptibility markers in murine and human melanoma

Suchergebnisse filtern